a close up of a bottle of alcohol

Promoting Gender Neutral HPV Vaccination: Protecting Everyone Equally

News

May 30, 2024

Human Papillomavirus (HPV) is a leading cause of cervical cancer and other malignancies, including anal, oropharyngeal, penile, vulvar, and vaginal cancers. While HPV vaccination programs have traditionally targeted girls to prevent cervical cancer, emerging evidence underscores the importance of vaccinating boys as well. Gender-neutral HPV vaccination ensures comprehensive protection against HPV-related diseases and contributes to herd immunity, significantly reducing the virus’s transmission within the population.

To discuss strategies for protecting everyone through gender-neutral HPV vaccination, the World Federation of Public Health Associations (WFPHA) held a high-level side event in conjunction with the 77th World Health Assembly (WHA) in Geneva. This event featured distinguished speakers and leaders in the field of public health, advocating for the global implementation of gender-neutral HPV vaccination programs. The primary aim was to raise awareness and promote inclusive vaccination strategies that protect both girls and boys from HPV-related diseases.

Chairs:

  • Dr. Michael Moore, WFPHA Past President
  • Dr. Marta Lomazzi, WFPHA Executive Manager

Opening Speech:

  • Dr. Rhonda Sealey-Thomas, Assistant Director PAHO

Speakers- Panel 1:

Speakers- Panel 2:

  • Jean Marie Okwo Bele is the former Director, Immunization and Vaccines Department at World Health Organisation & Consultant for AFR CDC

  • Ibtihal Fadhil is the Chair at Eastern Mediterranean NCD Alliance, Former Regional Adviser NCDs , WHO/EMRO

  • Martha Rebour is the Executive Director, Shot@life

  • Tristan Amalda is theNOMAN President and founder

  • Peter Baker is the Director of Global Action on Men’s Health